Site içinde arama yapın

Anuj Mrfr bir ses eklendi Health
2026-01-21 10:11:38 -

Peripheral Neuropathy Market: Is 2026 the Year We Finally "Silence" Chronic Nerve Pain?
As of January 21, 2026, the global peripheral neuropathy market is identifying as a high-stakes arena for medical breakthrough, with its 2026 valuation reaching approximately $2.2 billion to $2.75 billion, depending on the inclusion of specialized pharmacological treatments. The 2026 landscape is defined by a steady 5.5% to 9.01% CAGR, propelled by the urgent need to treat the 552 million...

0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme

Please log in to like, share and comment!
John Anderson bir ses eklendi Other
2026-06-04 13:06:06 -

Rising Demand Trends in the Chemotherapy Induced Peripheral Neuropathy Market
Chemotherapy-Induced Peripheral Neuropathy (CIPN) is one of the most common and challenging side effects associated with cancer therapy, affecting patients' quality of life and treatment outcomes. According to market estimates, the chemotherapy induced peripheral neuropathy market is expected to grow from US$ 1.01 billion in 2025 to US$ 1.67 billion by 2034, registering a CAGR of 5.71% during...

0 Yorumlar 0 hisse senetleri 246 Views 0 önizleme

Please log in to like, share and comment!
Divya Sawant bir ses eklendi Other
2026-04-09 11:48:21 -

US Chemotherapy-Induced Peripheral Neuropathy Market Growth Outlook: Innovation and Clinical Trials Driving Demand
The rising global burden of cancer has significantly increased the use of chemotherapy as a primary treatment approach. While chemotherapy plays a vital role in improving survival outcomes, it often leads to complications that affect patients’ quality of life. CIPN Market Overview and Growth AnalysisThe CIPN Market is expected to register an impressive CAGR of 27.6% from 2025 to...

0 Yorumlar 0 hisse senetleri 869 Views 0 önizleme

Please log in to like, share and comment!